Septerna (SEPN) Amortizatization of Intangibles (2024 - 2026)
Septerna's (SEPN) quarterly Amortizatization of Intangibles came in at $755000.0 in Q1 2026, down 21.76% year-on-year from $965000.0 in Q1 2025, and down 14.88% quarter-over-quarter from $887000.0 in Q4 2025.
Septerna (SEPN) Amortizatization of Intangibles (2024 - 2026) Analysis & Trends
Septerna's Amortizatization of Intangibles history runs 3 years deep, the most recent figure standing at $755000.0 for Q1 2026.
- On a quarterly basis, Amortizatization of Intangibles fell 21.76% year-over-year to $755000.0 in Q1 2026; TTM through Mar 2026 was $3.2 million, a 40.6% increase from a year earlier, with the FY2025 full-year figure at $3.4 million, up 144.54% from the prior year.
- Amortizatization of Intangibles slipped to $755000.0 in Q1 2026 per SEPN's latest filing, from $887000.0 in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $975000.0 in Q2 2025 and bottomed at $72000.0 in Q1 2024.
- The 3-year median for Amortizatization of Intangibles is $755000.0 (2026), against an average of $623666.7.
- Across the five-year window, Amortizatization of Intangibles jumped 1240.28% in 2025 and slipped 21.76% in 2026, its largest moves.
- Year by year, Amortizatization of Intangibles stood at $809000.0 in 2024, then grew by 9.64% to $887000.0 in 2025, then decreased by 14.88% to $755000.0 in 2026.
- Per Business Quant, the three latest SEPN Amortizatization of Intangibles figures stand at $755000.0 (Q1 2026), $887000.0 (Q4 2025), and $621000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 3.22 Mn |
| 10 | Septerna | 1.51 Bn | 1.51 Bn | - | 755,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 755,000.00 |
| Mar 31, 2026 | 755,000.00 |
| Dec 31, 2025 | 887,000.00 |
| Dec 31, 2025 | 887,000.00 |
| Sep 30, 2025 | 621,000.00 |
| Sep 30, 2025 | 621,000.00 |
| Jun 30, 2025 | 975,000.00 |
| Jun 30, 2025 | 975,000.00 |
| Mar 31, 2025 | 965,000.00 |
| Mar 31, 2025 | 965,000.00 |
| Dec 31, 2024 | 809,000.00 |
| Dec 31, 2024 | 809,000.00 |
| Sep 30, 2024 | 371,000.00 |
| Sep 30, 2024 | 371,000.00 |
| Jun 30, 2024 | 158,000.00 |
| Jun 30, 2024 | 158,000.00 |
| Mar 31, 2024 | 72,000.00 |
| Mar 31, 2024 | 72,000.00 |